Bill Amendment: IL SB3750 | 2025-2026 | 104th General Assembly

NOTE: For additional amemendments please see the Bill Drafting List
Bill Title: MENTAL HEALTH-COURT ORDERS

Status: 2026-06-30 - Added as Co-Sponsor Sen. Mary Edly-Allen [SB3750 Detail]

Download: Illinois-2025-SB3750-Senate_Amendment_004.html

Sen. Laura Fine

Filed: 5/29/2026

 

 


 

 


 
10400SB3750sam004LRB104 20663 KTG 38488 a

1
AMENDMENT TO SENATE BILL 3750

2    AMENDMENT NO. ______. Amend Senate Bill 3750, AS AMENDED,
3by replacing everything after the enacting clause with the
4following:
 
5    "Section 5. The Mental Health and Developmental
6Disabilities Code is amended by changing Sections 2-107,
72-107.1, 3-611, 3-806.1, 3-807, and 6-103 and by adding
8Section 3-707 as follows:
 
9    (405 ILCS 5/2-107)  (from Ch. 91 1/2, par. 2-107)
10    Sec. 2-107. Refusal of services; informing of risks.
11    (a) An adult recipient of services or the recipient's
12guardian, if the recipient is under guardianship, and the
13recipient's substitute decision maker, if any, must be
14informed of the recipient's right to refuse medication or
15electroconvulsive therapy. The recipient and the recipient's
16guardian or substitute decision maker shall be given the

 

 

10400SB3750sam004- 2 -LRB104 20663 KTG 38488 a

1opportunity to refuse generally accepted mental health or
2developmental disability services, including but not limited
3to medication or electroconvulsive therapy. If such services
4are refused, they shall not be given unless such services are
5necessary to prevent the recipient from causing serious and
6imminent physical harm to the recipient or others and no less
7restrictive alternative is available. The facility director
8shall inform a recipient, guardian, or substitute decision
9maker, if any, who refuses such services of alternate services
10available and the risks of such alternate services, as well as
11the possible consequences to the recipient of refusal of such
12services.
13    (b) Psychotropic medication or electroconvulsive therapy
14may be administered under this Section for up to 24 hours only
15if the circumstances leading up to the need for emergency
16treatment are set forth in writing in the recipient's record.
17    (c) Administration of medication or electroconvulsive
18therapy may not be continued unless the need for such
19treatment is redetermined at least every 24 hours based upon a
20personal examination of the recipient by a physician or a
21nurse under the supervision of a physician and the
22circumstances demonstrating that need are set forth in writing
23in the recipient's record.
24    (d) Neither psychotropic medication nor electroconvulsive
25therapy may be administered under this Section for a period in
26excess of 72 hours, excluding Saturdays, Sundays, and

 

 

10400SB3750sam004- 3 -LRB104 20663 KTG 38488 a

1holidays, unless a petition is filed under Section 2-107.1 and
2the treatment continues to be necessary under subsection (a)
3of this Section. Once the petition has been filed, treatment
4may continue in compliance with subsections (a), (b), and (c)
5of this Section until the final outcome of the hearing on the
6petition.
7    (e) The Department shall issue rules designed to ensure    
8insure that in State-operated mental health facilities
9psychotropic medication and electroconvulsive therapy are
10administered in accordance with this Section and only when
11appropriately authorized and monitored by a physician or a
12nurse under the supervision of a physician in accordance with
13accepted medical practice. The facility director of each
14mental health facility not operated by the State shall issue
15rules designed to ensure insure that in that facility
16psychotropic medication and electroconvulsive therapy are
17administered in accordance with this Section and only when
18appropriately authorized and monitored by a physician or a
19nurse under the supervision of a physician in accordance with
20accepted medical practice. Such rules shall be available for
21public inspection and copying during normal business hours.
22    (f) The provisions of this Section with respect to the
23emergency administration of psychotropic medication and
24electroconvulsive therapy do not apply to facilities licensed
25under the Nursing Home Care Act, the Specialized Mental Health
26Rehabilitation Act of 2013, the ID/DD Community Care Act, or

 

 

10400SB3750sam004- 4 -LRB104 20663 KTG 38488 a

1the MC/DD Act.
2    (g) Under no circumstances may long-acting psychotropic
3medications be administered under this Section.
4    (h) Whenever psychotropic medication or electroconvulsive
5therapy is refused pursuant to subsection (a) of this Section
6at least once that day, the physician or advanced practice
7psychiatric nurse shall determine and state in writing the
8reasons why the recipient did not meet the criteria for
9administration of medication or electroconvulsive therapy
10under subsection (a) and whether the recipient meets the
11standard for administration of psychotropic medication or
12electroconvulsive therapy under Section 2-107.1 of this Code.
13If the physician or advanced practice psychiatric nurse    
14determines that the recipient meets the standard for
15administration of psychotropic medication or electroconvulsive
16therapy under Section 2-107.1, the facility director or his or
17her designee shall petition the court for administration of
18psychotropic medication or electroconvulsive therapy pursuant
19to that Section unless the facility director or his or her
20designee states in writing in the recipient's record why the
21filing of such a petition is not warranted. This subsection
22(h) applies only to State-operated mental health facilities.
23    (i) The Department shall conduct annual trainings for all
24physicians and registered nurses working in State-operated
25mental health facilities on the appropriate use of emergency
26administration of psychotropic medication and

 

 

10400SB3750sam004- 5 -LRB104 20663 KTG 38488 a

1electroconvulsive therapy, standards for their use, and the
2methods of authorization under this Section.
3(Source: P.A. 98-104, eff. 7-22-13; 99-180, eff. 7-29-15.)
 
4    (405 ILCS 5/2-107.1)  (from Ch. 91 1/2, par. 2-107.1)
5    Sec. 2-107.1. Administration of psychotropic medication
6and electroconvulsive therapy upon application to a court.
7    (a) (Blank).
8    (a-5) Notwithstanding the provisions of Section 2-107 of
9this Code, psychotropic medication and electroconvulsive
10therapy may be administered to an adult recipient of services
11on an inpatient or outpatient basis without the informed
12consent of the recipient under the following standards:
13        (1) Any person 18 years of age or older, including any
14    guardian, may petition the circuit court for an order
15    authorizing the administration of psychotropic medication
16    and electroconvulsive therapy to a recipient of services.
17    The petition shall state that the petitioner has made a
18    good faith attempt to determine whether the recipient has
19    executed a power of attorney for health care under the
20    Powers of Attorney for Health Care Law or a declaration
21    for mental health treatment under the Mental Health
22    Treatment Preference Declaration Act and to obtain copies
23    of these instruments if they exist. If either of the
24    above-named instruments is available to the petitioner,
25    the instrument or a copy of the instrument shall be

 

 

10400SB3750sam004- 6 -LRB104 20663 KTG 38488 a

1    attached to the petition as an exhibit. The petitioner
2    shall deliver a copy of the petition, and notice of the
3    time and place of the hearing, to the respondent, his or
4    her attorney, any known agent or attorney-in-fact, if any,
5    and the guardian, if any, no later than 3 days prior to the
6    date of the hearing. Service of the petition and notice of
7    the time and place of the hearing may be made upon parties
8    other than the respondent by transmitting them via
9    facsimile machine, secure or encrypted electronic mail, or
10    by operation of an electronic filing manager service
11    authorized by the Supreme Court. Service of the petition
12    and notice of the time and place of the hearing upon a
13    respondent may be accomplished by any one of the
14    following:
15            (A) In a manner authorized by Sections 2-202 and
16        2-203 of the Code of Civil Procedure.
17            (B) Handing a copy of the petition and notice to
18        the respondent together with a waiver of personal
19        service. The waiver may be returned to the party
20        delivering the petition and notice. If the party
21        delivering the petition and notice to the respondent
22        does not receive the waiver, the service must be by
23        personal service.
24            (C) If the respondent is an inpatient in a mental
25        health facility, handing a copy of the petition and
26        notice to the respondent, provided the party

 

 

10400SB3750sam004- 7 -LRB104 20663 KTG 38488 a

1        delivering the petition and notice to the respondent
2        files within 24 hours a certification naming the party
3        served and stating the means, place, date, and time of
4        service. The certification may be contained in the
5        body of the petition for authorization to administer
6        psychotropic medications/electroconvulsive therapy.
7        If no certification of service is filed before the
8        matter is set for hearing, then service must be made by
9        personal service. to the respondent or other party.
10        Upon receipt of the petition and notice, the party
11        served, or the person delivering the petition and
12        notice to the party served, shall acknowledge service.
13        If the party sending the petition and notice does not
14        receive acknowledgement of service within 24 hours,
15        service must be made by personal service.
16        A petition seeking authorization for the
17    administration of psychotropic medication shall state the
18    name of each psychotropic medication for which
19    authorization is sought and the anticipated range of
20    dosages for each such medication.    
21        A petition may also request authorization for
22    alternative or alternate psychotropic medications. Any
23    such request shall state the name of each alternative or
24    alternate psychotropic medication, the anticipated range
25    of dosages for each such medication, and any combinations
26    of medications or therapeutic classifications of specified

 

 

10400SB3750sam004- 8 -LRB104 20663 KTG 38488 a

1    medications that may be administered simultaneously.    
2        The information required under this subsection may
3    appear in the body of the petition or in an exhibit
4    attached to and expressly incorporated into the petition.    
5    The petition may include a request that the court
6    authorize such testing and procedures as may be essential
7    for the safe and effective administration of the
8    psychotropic medication or electroconvulsive therapy
9    sought to be administered, but only where the petition
10    sets forth the specific testing and procedures sought to
11    be administered.
12        If a hearing is requested to be held immediately
13    following the hearing on a petition for involuntary
14    admission, then the notice requirement shall be the same
15    as that for the hearing on the petition for involuntary
16    admission, and the petition filed pursuant to this Section
17    shall be filed with the petition for involuntary
18    admission.
19        (2) The court shall hold a hearing within 7 days of the
20    filing of the petition. The People, the petitioner, or the
21    respondent shall be entitled to a continuance of up to 7
22    days as of right. An additional continuance of not more
23    than 7 days may be granted to any party (i) upon a showing
24    that the continuance is needed in order to adequately
25    prepare for or present evidence in a hearing under this
26    Section or (ii) under exceptional circumstances. The court

 

 

10400SB3750sam004- 9 -LRB104 20663 KTG 38488 a

1    may grant an additional continuance not to exceed 21 days
2    when, in its discretion, the court determines that such a
3    continuance is necessary in order to provide the recipient
4    with an examination pursuant to Section 3-803 or 3-804 of
5    this Act, to provide the recipient with a trial by jury as
6    provided in Section 3-802 of this Act, or to arrange for
7    the substitution of counsel as provided for by the
8    Illinois Supreme Court Rules. The hearing shall be
9    separate from a judicial proceeding held to determine
10    whether a person is subject to involuntary admission but
11    may be heard immediately preceding or following such a
12    judicial proceeding and may be heard by the same trier of
13    fact or law as in that judicial proceeding.
14        (3) Unless otherwise provided herein, the procedures
15    set forth in Article VIII of Chapter III of this Act,
16    including the provisions regarding appointment of counsel,
17    shall govern hearings held under this subsection (a-5).
18        (4) Psychotropic medication and electroconvulsive
19    therapy may be administered to the recipient if and only
20    if it has been determined by clear and convincing evidence
21    that all of the following factors are present. In
22    determining whether a person meets the criteria specified
23    in the following paragraphs (A) through (G), the court may
24    consider evidence of the person's history of serious
25    violence, repeated past pattern of specific behavior,
26    actions related to the person's illness, or past outcomes

 

 

10400SB3750sam004- 10 -LRB104 20663 KTG 38488 a

1    of various treatment options.
2            (A) That the recipient has a serious mental
3        illness or developmental disability.
4            (B) That because of said mental illness or
5        developmental disability, the recipient currently
6        exhibits any one of the following: (i) deterioration
7        of his or her ability to function, as compared to the
8        recipient's ability to function prior to the current
9        onset of symptoms of the mental illness or disability
10        for which treatment is presently sought, (ii)
11        suffering, or (iii) threatening behavior.
12            (C) That the illness or disability has existed for
13        a period marked by the continuing presence of the
14        symptoms set forth in item (B) of this subdivision (4)
15        or the repeated episodic occurrence of these symptoms.
16            (D) That the benefits of the treatment outweigh
17        the harm.
18            (E) That the recipient lacks the capacity to make
19        a reasoned decision about the treatment.
20            (F) That other less restrictive services have been
21        explored and found inappropriate.
22            (G) If the petition seeks authorization for
23        testing and other procedures, that such testing and
24        procedures are essential for the safe and effective
25        administration of the treatment.
26        (5) In no event shall an order issued under this

 

 

10400SB3750sam004- 11 -LRB104 20663 KTG 38488 a

1    Section be effective for more than 90 days. A second
2    90-day period of involuntary treatment may be authorized
3    pursuant to a hearing that complies with the standards and
4    procedures of this subsection (a-5). Thereafter,
5    additional 180-day periods of involuntary treatment may be
6    authorized pursuant to the standards and procedures of
7    this Section without limit. If a new petition to authorize
8    the administration of psychotropic medication or
9    electroconvulsive therapy is filed at least 15 days prior
10    to the expiration of the prior order, and if any
11    continuance of the hearing is agreed to by the recipient,
12    the administration of the treatment may continue in
13    accordance with the prior order pending the completion of
14    a hearing under this Section.
15        (6) An order issued under this subsection (a-5) shall
16    designate the persons authorized to administer the
17    treatment under the standards and procedures of this
18    subsection (a-5). Those persons shall have complete
19    discretion not to administer any treatment authorized
20    under this Section. The order shall also specify the
21    medications and the anticipated range of dosages that have
22    been authorized and may include a list of any alternative
23    medications and range of dosages deemed necessary.
24    (a-10) The court may, in its discretion, appoint a
25guardian ad litem for a recipient before the court or
26authorize an existing guardian of the person to monitor

 

 

10400SB3750sam004- 12 -LRB104 20663 KTG 38488 a

1treatment and compliance with court orders under this Section.
2    (b) A guardian may be authorized to consent to the
3administration of psychotropic medication or electroconvulsive
4therapy to an objecting recipient only under the standards and
5procedures of subsection (a-5).
6    (c) Notwithstanding any other provision of this Section, a
7guardian may consent to the administration of psychotropic
8medication or electroconvulsive therapy to a non-objecting
9recipient under Article XIa of the Probate Act of 1975.
10    (d) Nothing in this Section shall prevent the
11administration of psychotropic medication or electroconvulsive
12therapy to recipients in an emergency under Section 2-107 of
13this Act.
14    (e) Notwithstanding any of the provisions of this Section,
15psychotropic medication or electroconvulsive therapy may be
16administered pursuant to a power of attorney for health care
17under the Powers of Attorney for Health Care Law or a
18declaration for mental health treatment under the Mental
19Health Treatment Preference Declaration Act over the objection
20of the recipient if the recipient has not revoked the power of
21attorney or declaration for mental health treatment as
22provided in the relevant statute.
23    (f) The Department shall conduct annual trainings for
24physicians and registered nurses working in State-operated
25mental health facilities on the appropriate use of
26psychotropic medication and electroconvulsive therapy,

 

 

10400SB3750sam004- 13 -LRB104 20663 KTG 38488 a

1standards for their use, and the preparation of court
2petitions under this Section before any such psychiatrists or
3advanced practice psychiatric nurses may petition the court or
4testify at a hearing under this Section.
5(Source: P.A. 100-710, eff. 8-3-18.)
 
6    (405 ILCS 5/3-611)  (from Ch. 91 1/2, par. 3-611)
7    Sec. 3-611. Filing petition, first certificate, and proof
8of service.        
9    (a) Within 24 hours, excluding Saturdays, Sundays and
10holidays, after the respondent's admission under this Article,
11the facility director of the facility shall file 2 copies of
12the petition, the first certificate, and proof of service of
13the petition and statement of rights upon the respondent with
14the court in the county in which the facility is located.
15    (b) Upon completion of the second certificate, the
16facility director shall promptly file it with the court and
17provide a copy to the respondent.
18    (c) The facility director shall make copies of the
19certificates available to the attorneys for the parties upon
20request.
21    (d) Upon the filing of the petition and first certificate,
22the court shall set a hearing to be held within 5 days,
23excluding Saturdays, Sundays and holidays, after receipt of
24the petition. The court shall direct that notice of the time
25and place of the hearing be served upon the respondent, his

 

 

10400SB3750sam004- 14 -LRB104 20663 KTG 38488 a

1responsible relatives, and the persons entitled to receive a
2copy of the petition pursuant to Section 3-609.
3(Source: P.A. 98-865, eff. 8-8-14.)
 
4    (405 ILCS 5/3-707 new)
5    Sec. 3-707. Dismissal of petition; discharge of
6respondent. If a petition alleging that the respondent is
7subject to involuntary admission is voluntarily or
8involuntarily dismissed prior to a hearing, the court shall
9order that the respondent be discharged from involuntary
10admission and the respondent be allowed to leave the mental
11health facility, unless, upon a good-faith representation that
12the petitioner will file a legally sufficient petition under
13the requirements of Article VI, the court shall delay the
14effectiveness of its order for 24 hours, excluding Saturdays,
15Sundays, and holidays. This Section does not preclude the
16respondent from seeking informal or voluntary admission to a
17mental health facility. In determining whether a good-faith
18representation has been made, the court may consider the
19nature of the defect requiring dismissal of the petition, any
20previous or successive filings of petitions associated with
21the respondent's current hospitalization, the nature of the
22defect requiring dismissal of any previous or successive
23filings, the respondent's current condition, and any other
24relevant factors the court deems appropriate. The court may
25request testimonial evidence to determine if good faith has

 

 

10400SB3750sam004- 15 -LRB104 20663 KTG 38488 a

1been shown. Notwithstanding the foregoing, the petitioner may
2amend the petition at any time prior to judgment with leave
3from the court on just and reasonable terms.
 
4    (405 ILCS 5/3-806.1)
5    Sec. 3-806.1. Video conferencing.
6    (a) Notwithstanding the provisions in Sections Section    
73-806 and 3-807, the Illinois Supreme Court or any circuit
8court of this State may adopt rules permitting the use of video
9conferencing equipment in all hearings under this Chapter
10subject to the following provisions:
11        (1) Such hearings are permitted if the parties,
12    including the respondent, and their lawyers, including the
13    State's Attorney, are at a mental health facility, or some
14    other location to which the respondent may be safely and
15    conveniently transported, and the judge and any court
16    personnel are in another location.
17        (2) Such hearings are permitted if the respondent and
18    his or her counsel are at a mental health facility or some
19    other location to which the respondent may be safely and
20    conveniently transported, and all of the other
21    participants including the judge are in another location,
22    if, and only if, agreed to by the respondent and the
23    respondent's counsel.
24        (3) Video conferencing under this subsection (a) shall
25    not be permitted in a jury trial under Section 3-802 of

 

 

10400SB3750sam004- 16 -LRB104 20663 KTG 38488 a

1    this Article.
2    (b) Notwithstanding the above provisions, any court may
3permit any witness, including a psychiatrist, to testify by
4video conferencing equipment from any location in the absence
5of a court rule specifically prohibiting such testimony.
6(Source: P.A. 96-1321, eff. 1-1-11.)
 
7    (405 ILCS 5/3-807)  (from Ch. 91 1/2, par. 3-807)
8    Sec. 3-807. Testimony.    No respondent may be found subject
9to involuntary admission on an inpatient or outpatient basis
10unless at least one psychiatrist, clinical social worker,
11clinical psychologist, advanced practice psychiatric nurse, or
12qualified examiner who has examined the respondent testifies
13in person except as provided by Section 3-806.1 at the
14hearing. The respondent may waive the requirement of the
15testimony subject to the approval of the court.
16(Source: P.A. 101-587, eff. 1-1-20.)
 
17    (405 ILCS 5/6-103)  (from Ch. 91 1/2, par. 6-103)
18    Sec. 6-103. (a) All persons acting in good faith and
19without negligence in connection with the preparation of
20applications, petitions, certificates or other documents, for
21the apprehension, transportation, examination, treatment,
22habilitation, detention or discharge of an individual or
23compliance with a court order for discharge under the
24provisions of this Act incur no liability, civil or criminal,    

 

 

10400SB3750sam004- 17 -LRB104 20663 KTG 38488 a

1by reason of such acts including: .
2        (1) any civil liability;
3        (2) any criminal liability; or
4        (3) any discipline for unprofessional conduct.    
5    (b) There shall be no liability on the part of, and no
6cause of action shall arise against, any person who is a
7physician, clinical psychologist, advanced practice
8psychiatric nurse, or qualified examiner based upon that
9person's failure to warn of and protect from a recipient's
10threatened or actual violent behavior except where the
11recipient has communicated to the person a serious threat of
12physical violence against a reasonably identifiable victim or
13victims. Nothing in this Section shall relieve any employee or
14director of any residential mental health or developmental
15disabilities facility from any duty he may have to protect the
16residents of such a facility from any other resident.
17    (c) Any duty which any person may owe to anyone other than
18a resident of a mental health and developmental disabilities
19facility shall be discharged by that person making a
20reasonable effort to communicate the threat to the victim and
21to a law enforcement agency, or by a reasonable effort to
22obtain the hospitalization of the recipient.
23    (d) An act of omission or commission by a peace officer
24acting in good faith in rendering emergency assistance or
25otherwise enforcing this Code does not impose civil liability
26on the peace officer or his or her supervisor or employer

 

 

10400SB3750sam004- 18 -LRB104 20663 KTG 38488 a

1unless the act is a result of willful or wanton misconduct.
2    (e) For purposes of this Section, "person" includes and
3applies to a body politic and corporate as well as to an
4individual.    
5(Source: P.A. 104-270, eff. 8-15-25.)".
feedback